Fibro Daily

Avacen 100 Receives EU Approval

Fibro Daily January 5, 2017


Fibromyalgia News Today brings us the latest treatment news from Avacen:

Avacen Medical has received approval to market its Avacen 100 device, which decreases pain associated with fibromyalgia (FM), in the European Union. Avacen 100 is an FDA-approved, drug-free, non-invasive device that heats the circulatory system to promote muscle relaxation and reduce pain.

Avacen focuses on drug-free pain management.

Read more:

Avacen 100 Device for Relieving Fibromyalgia Pain Earns EU Marketing Approval



Powered by Facebook Comments

Leave a Comment

Login to your account

Can't remember your Password ?

Register for this site!